New Drug Proves Highly Effective for Killing Off B Cell Non-Hodgkin's Lymphoma
Mayo ClinicA Mayo Clinic study indicates the first of a new class of drugs involving radioimmunotherapy benefited a significant number of patients with low-grade B cell non-Hodgkin's lymphoma who have exhausted treatment options.